Document Classification

Section Type: METHODS

Text: Between February 1994 and April 2000, 166 men with good-prognosis metastatic germ cell tumors defined by modified Memorial Sloan-Kettering criteria were randomly assigned to receive 3B (90) E (500) P (three cycles, repeated every 21 days, of 30 kU bleomycin on days 1, 8, and 15 ; 100 mg/m (2) etoposide on days 1-5 ; and 20 mg/m (2) cisplatin on days 1-5 ; n = 83) or 4B (30) E (360) P (four cycles, repeated every 21 days, of 30 kU bleomycin on day 1, 120 mg/m (2) etoposide on days 1-3, and 100 mg/m (2) cisplatin on day 1 ; n = 83).